The hematopoietic growth factors are potent regulators of blood-cell proliferation and development. The first phase of clinical trials suggests that they may augment hematopoiesis in a number of different conditions of primary and secondary bone marrow dysfunction. Future clinical use is likely to include combinations of these growth factors, in order to stimulate early marrow progenitors and obtain multilineage effects. An improved understanding of the biologic and clinical effects of hematopoietic growth factors promises future clinical applications for conditions of impaired function and reduced numbers of blood cells.
Source Information
Division of Hematology/Oncology, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02215.
This article has been cited by other articles:
Jacene, H. A., Ishimori, T., Engles, J. M., Leboulleux, S., Stearns, V., Wahl, R. L.
(2006). Effects of Pegfilgrastim on Normal Biodistribution of 18F-FDG: Preclinical and Clinical Studies. JNM
47: 950-956
[Abstract][Full Text]
Hartman, R. P., Sundaram, M., Okuno, S. H., Sim, F. H.
(2004). Effect of Granulocyte-Stimulating Factors on Marrow of Adult Patients with Musculoskeletal Malignancies: Incidence and MRI Findings. Am. J. Roentgenol.
183: 645-653
[Abstract][Full Text]
Stevenson, N. J., Haan, S., McClurg, A. E., McGrattan, M. J., Armstrong, M. A., Heinrich, P. C., Johnston, J. A.
(2004). The Chemoattractants, IL-8 and Formyl-Methionyl-Leucyl-Phenylalanine, Regulate Granulocyte Colony-Stimulating Factor Signaling by Inducing Suppressor of Cytokine Signaling-1 Expression. J. Immunol.
173: 3243-3249
[Abstract][Full Text]
Yao, G.-Q., Sun, B.-h., Insogna, K. L., Weir, E. C.
(2000). Nuclear Factor-{kappa}B p50 Is Required for Tumor Necrosis Factor-{alpha}-Induced Colony-Stimulating Factor-1 Gene Expression in Osteoblasts. Endocrinology
141: 2914-2922
[Abstract][Full Text]
Harris, D. T., Sakiestewa, D., Robledo, R. F., Young, R. S., Witten, M.
(2000). Effects of short-term JP-8 jet fuel exposure on cell-mediated immunity. Toxicol Ind Health
16: 78-84
[Abstract]
Mueller, M. M., Herold-Mende, C. C., Riede, D., Lange, M., Steiner, H.-H., Fusenig, N. E.
(1999). Autocrine Growth Regulation by Granulocyte Colony-Stimulating Factor and Granulocyte Macrophage Colony-Stimulating Factor in Human Gliomas with Tumor Progression. Am. J. Pathol.
155: 1557-1567
[Abstract][Full Text]
Pujol, J.-L., Lafontaine, T., Quantin, X., Reme-Saumon, M., Cupissol, D., Khial, F., Michel, F.-B.
(1999). Neoadjuvant Etoposide, Ifosfamide, and Cisplatin Followed by Concomitant Thoracic Radiotherapy and Continuous Cisplatin Infusion in Stage IIIb Non-small Cell Lung Cancer. Chest
115: 144-150
[Abstract][Full Text]
Esser, R., Glienke, W., Andreesen, R., Unger, R. E., Kreutz, M., Rubsamen-Waigmann, H., von Briesen, H.
(1998). Individual Cell Analysis of the Cytokine Repertoire in Human Immunodeficiency Virus-1-Infected Monocytes/Macrophages by a Combination of Immunocytochemistry and In Situ Hybridization. Blood
91: 4752-4760
[Abstract][Full Text]
Vera, J. C., Rivas, C. I., Zhang, R. H., Golde, D. W.
(1998). Colony-Stimulating Factors Signal for Increased Transport of Vitamin C in Human Host Defense Cells. Blood
91: 2536-2546
[Abstract][Full Text]
Borgbjerg, B. M., Hovgaard, D., Laursen, J. B., Aldershvile, J.
(1998). Granulocyte colony stimulating factor in neutropenic patients with infective endocarditis. Heart
79: 93-95
[Abstract][Full Text]
Hartmann, L. C., Tschetter, L. K., Habermann, T. M., Ebbert, L. P., Johnson, P. S., Mailliard, J. A., Levitt, R., Suman, V. J., Witzig, T. E., Wieand, H.S., Miller, L. L., Moertel, C. G., Grendahl, D. C., Herrera, D. M.
(1997). Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile Neutropenia. NEJM
336: 1776-1780
[Abstract][Full Text]
Harker, L. A., Marzec, U. M., Kelly, A. B., Cheung, E., Tomer, A., Nichol, J. L., Hanson, S. R., Stead, R. B.
(1997). Prevention of Thrombocytopenia and Neutropenia in a Nonhuman Primate Model of Marrow Suppressive Chemotherapy by Combining Pegylated Recombinant Human Megakaryocyte Growth and Development Factor and Recombinant Human Granulocyte Colony-Stimulating Factor. Blood
89: 155-165
[Abstract][Full Text]
Ignoffo, R. J., King, R.
(1995). Pharmaceutical care and the cancer patient. J Oncol Pharm Pract
1: 7-19
[Abstract]
D'Andrea, A. D.
(1994). Cytokine Receptors in Congenital Hematopoietic Disease. NEJM
330: 839-846
[Full Text]
Pizzo, P. A.
(1993). Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia. NEJM
328: 1323-1332
[Full Text]
Durivage, H. J., Burnham, N. L.
(1991). Prevention and Management of Toxicities Associated With Antineoplastic Drugs. Journal of Pharmacy Practice
4: 27-48
Betcher, D. L., Burnham, N.
(1991). Granulocyte-Macrophage Colony-Stimulating Factor. Journal of Pediatric Oncology Nursing
8: 134-135
Previous
